Press Releases

Lab Informatics Expert Joins bioMérieux

July 19, 2010. A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology. Mr. Baudin has 2...

Congrès annuel 2010 de l’American Society of Clinical Oncology. bioTheranostics présente les données issues des études cliniques* sur ses tests de diagnostic moléculaire, CancerType ID® et Breast Cancer Index®

SAN DIEGO, Californie - 6 juin 2010. bioTheranostics, une filiale de bioMérieux qui développe des tests de diagnostic innovants dans le domaine de l’oncologie pour aider à la mise en place de traiteme...

bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

Marcy l’Etoile, France - May 25, 2010. Innovative solution optimizes laboratory workflow and clinical information management. A world leader in in vitro diagnostics, bioMérieux presented Myla™, a revo...

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology

Kyoto, Japan and Marcy l’Etoile, France - May 21, 2010. Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial ident...

bioMérieux Strengthens North American Executive Management Team

Marcy l’Etoile, France - May 17, 2010. Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc. A world leader in in vitro diagnostics, bioMérieux today announced ...

bioMérieux Co-sponsors French Medical Days in Shanghai

Marcy l’Etoile, France - May 17, 2010. bioMérieux plays a driving role in Sino-French healthcare cooperation: Organization of seminar on emergency medicine Inauguration of Sino-French Emergency Satell...

Partenariat entre bioMérieux et GSK pour le développement d’un test moléculaire de théranostic pour le choix de traitements anticancéreux

Marcy l’Etoile (France) - 10 mai 2010. bioMérieux et GlaxoSmithKline (GSK) ont conclu un accord pour le développement d’un test moléculaire novateur dans le domaine du cancer. Dans le cadre de cette n...

bioMérieux - First Quarter 2010 Business Review

Marcy l'Etoile, France - April 21, 2010. Sales up 6.4% at constant exchange rates and scope of consolidation. bioMérieux, a world leader in the field of in vitro diagnostics, today released its busine...

bioMérieux and Knome Sign Strategic Partnership

Marcy l'Etoile (France) and Cambridge, Massachusetts (USA) - April 21, 2010. Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market. bioMérieux t...

AnagnosTec cède à bioMérieux une banque de données et un savoir-faire en identification microbienne rapide par spectrométrie de masse

bioMérieux présente à l’ECCMID le système Myla™, nouvelle solution informatique pour transformer le laboratoire de microbiologie

Marcy l’Etoile, France - April 12, 2010. Innovative software: consolidates and transforms microbiology laboratory data into actionable information for treatment decisions recaptures time for lab manag...

bioMérieux Acquires from AnagnosTec - Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry

Marcy l’Etoile, France - April 12, 2010. bioMérieux announces today that it has agreed on the terms for the acquisition of certain assets from AnagnosTec, a company based in the greater Berlin area, s...

bioMérieux’s PREVI™ Isola Wins the 2010 - Medical Design Excellence Award

Marcy l’Etoile, France - April 8, 2010. The award highlights the automated media streaker’s breakthrough technology. A world leader in in vitro diagnostics, bioMérieux announced today that its automat...

bioMérieux 2015

Marcy l'Etoile, France - March 8, 2010. A powerful strategic vision for 2010-2015, driven by innovation and international development.

bioMérieux results 2009

Marcy l'Etoile, France - March 8, 2010. Solid operating and financial performance: Strong growth in sales: up 10.4% - At constant exchange rates Significant increase in operating margin: up 14.1%, at ...